首页 | 本学科首页   官方微博 | 高级检索  
     

超滤治疗在难治性心力衰竭中的研究进展
引用本文:杨佳汇,王进,孟祥旭,惠学志. 超滤治疗在难治性心力衰竭中的研究进展[J]. 临床医学, 2019, 39(3): 123-124,F0003
作者姓名:杨佳汇  王进  孟祥旭  惠学志
作者单位:河南大学第一附属医院心血管内科一病区,开封 475000;河南大学第一附属医院心血管内科一病区,开封 475000;河南大学第一附属医院心血管内科一病区,开封 475000;河南大学第一附属医院心血管内科一病区,开封 475000
摘    要:难治性心力衰竭患者不仅表现为心功能的减退,同时还合并有多器官功能障碍,不能有效治疗者预后较差。难治性心力衰竭的治疗方法主要分为药物性治疗和非药物性治疗两大类,其中药物性治疗是目前临床主要采用的治疗手段,但非药物性治疗如超滤治疗作为难治性心力衰竭的一种辅助治疗亦取得了进展。

关 键 词:超滤治疗  难治性心力衰竭

Advances in ultrafiltration therapy for intractable heart failure heart failure
Yang Jiahui,Wang Jin,Meng Xiangxu,Hui Xuezhi. Advances in ultrafiltration therapy for intractable heart failure heart failure[J]. Clinical Medicine, 2019, 39(3): 123-124,F0003
Authors:Yang Jiahui  Wang Jin  Meng Xiangxu  Hui Xuezhi
Affiliation:(Department of Cardiovascular Medicine,the First Affiliated Hospital of Henan University,Kaifeng 475000,China)
Abstract:Objective Patients with refractory heart failure not only show the decrease of cardiac function,but also merge with multiple organ dysfunction,and the prognosis of those who cannot be effectively treated is poor.The treatment methods of refractory heart failure are mainly divided into two categories,drug therapy and non-pharmacological treatment,among which drug therapy is the main treatment used in clinic at present,but non-pharmacological treatment such as ultrafiltration therapy as an adjuvant treatment of refractory heart failure has also made progress.
Keywords:Ultrafiltration treatment  Intractable heart failure  Ultrafiltration therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号